Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c0982b0f02b1ed6d20a315370a3a3a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2002-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b80d3693f700c7634f8960b7d9f57552 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e62c610bbb57af8e383fde278aab9f8 |
publicationDate |
2003-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2003008307-A1 |
titleOfInvention |
Methods for diagnosing activated protein C resistance associated with a factor V genetic mutation and compositions thereof |
abstract |
A method for identifying a Factor V gene mutation resulting in activated protein C resistance comprising detecting in a nucleic acid sample isolated from a human the presence of a genetic mutation characterized as a change from a guanine nucleotide to an adenine nucleotide at nucleotide position 205 in exon 10 of the Factor V gene that is associated with replacement of arginine 506 by glutamine, thereby identifying said mutation. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005053975-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7354715-B2 |
priorityDate |
1995-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |